Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family history

Author:

Jenkins Mark A.ORCID,Win Aung K.ORCID,Dowty James G.,MacInnis Robert J.,Makalic Enes,Schmidt Daniel F.,Dite Gillian S.,Kapuscinski Miroslaw,Clendenning Mark,Rosty Christophe,Winship Ingrid M.,Emery Jon D.,Saya Sibel,Macrae Finlay A.,Ahnen Dennis J.,Duggan David,Figueiredo Jane C.,Lindor Noralane M.,Haile Robert W.,Potter John D.,Cotterchio Michelle,Gallinger Steven,Newcomb Polly A.,Buchanan Daniel D.,Casey Graham,Hopper John L.

Abstract

ABSTRACTBackgroundA number of single nucleotide polymorphisms (SNPs), which are common inherited genetic variants, have been identified that are associated with risk of colorectal cancer. The aim of this study was to determine the ability of these SNPs to estimate colorectal cancer (CRC) risk for persons with and without a family history of CRC, and the screening implications.MethodsWe estimated the association with CRC of a 45 SNP-based risk using 1,181 cases and 999 controls, and its correlation (r) with CRC risk predicted from detailed family history. We estimated the predicted change in the distribution across predefined risk categories, and implications for recommended age to commence screening, from adding SNP-based risk to family history.ResultsThe inter-quintile risk ratio for colorectal cancer risk of the SNP-based risk was 2.46 (95% CI 1.91 – 3.11). SNP-based and family history-based risks were not correlated (r = 0.02). For persons with no first-degree relatives with CRC, recommended screening would commence 2 years earlier for women (4 years for men) in the highest quintile of SNP-based risk, and 12 years later for women (7 years for men) in the lowest quintile. For persons with two first-degree relatives with CRC, recommended screening would commence 15 years earlier for men and women in the highest quintile, and 8 years earlier for men and women in the lowest quintile.ConclusionsRisk reclassification by 45 SNPs could inform targeted screening for CRC prevention, particularly in clinical genetics settings when mutations in high-risk genes cannot be identified.

Publisher

Cold Spring Harbor Laboratory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3